Healthpeak PropertiesNYSE: PEAK

HMS Networks AB (publ) (“HMS”) has today completed the previously announced acquisition of 100 percent of the shares in PEAK-System Technik GmbH (“PEAK-System”), a well-established German provider of industrial communication solutions.

Healthpeak Properties, Inc. (NYSE:DOC ) Q3 2024 Earnings Conference Call October 25, 2024 10:00 AM ET Company Participants Andrew Johns - Senior Vice President, IR Scott Brinker - President and CEO Peter Scott - Chief Financial Officer Scott Bohn - Chief Development Officer & Head of Lab Tom Klaritch - Chief Operating Officer Conference Call Participants Nick Yulico - Scotiabank Joshua Dennerlein - Bank of America Austin Wurschmidt - KeyBanc Capital Markets Juan Sanabria - BMO Capital Markets John Kilichowski - Wells Fargo Rich Anderson - Wedbush Michael Griffin - Citi Group Michael Carroll - RBC Capital Markets Derrick Metzler - Morgan Stanley Wes Golladay - Baird John Pawlowski - Green Street Jim Kammert - Evercore Mike Mueller - JPMorgan Operator Good morning. And welcome to the Healthpeak Properties, Inc.'s Third Quarter Conference Call.

HMS Networks AB (publ) (“HMS”), a global provider of industrial information and communication technology, has today entered into a binding agreement with DOGAWIST-Investment GmbH to acquire 100% of the shares in PEAK-System Technik GmbH (“PEAK-System”), a well-established German provider of industrial communication solutions.

The margin of safety, introduced by Benjamin Graham, emphasizes diversification to protect against volatility and human errors, enhancing the probability of profitable outcomes. Healthpeak Properties, Plymouth Industrial REIT, and Realty Income are highlighted as REITs with a significant margin of safety, each rated as a Buy. Healthpeak Properties benefits from a merger, strong earnings, and a diversified healthcare portfolio, trading at a discount with a 5.45% dividend yield.

High demand for lab assets and rising senior citizens' healthcare spending are likely to support DOC's performance.

Healthpeak Properties is a leading U.S. real estate investment trust focused on medical office buildings, poised for long-term growth. The merger with Physician Realty Trust has increased the trust's portfolio to 748 properties, with potential for $80 million in synergies. With a steady dividend and strong funds from operations growth, Healthpeak Properties is a compelling investment for passive income investors.

WALTHAM, Mass. and BOULDER, Colo., May 23, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc.  (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced positive updated lead-in data from the company's ongoing Phase 3 PEAK trial evaluating the selective and potent KIT mutant inhibitor, bezuclastinib, in combination with sunitinib, in patients with Gastrointestinal Stromal Tumors (GIST). The data will be presented in a poster presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL on June 1. Cogent also announced today a new Phase 2 clinical trial of bezuclastinib plus sunitinib in later line GIST patients, sponsored by the Sarcoma Alliance for Research through Collaboration (SARC) and in collaboration with The Life Raft Group and Dana-Farber Cancer Institute.

Healthpeak (PEAK) closes its merger with Physicians Realty Trust, positioning it well to capitalize on the secular trends of the industry.

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that Scott Brinker, its President and Chief Executive Officer, is scheduled to present at the Citi 2024 Global Property CEO Conference. The presentation is scheduled for 11:40 a.m. Eastern Time on Tuesday, March 5, 2024. You can access the webcast by visiting our website at https://ir.healthpeak.com/news-events/default.